Changing paradigms—an update on the multidisciplinary management of malignant glioma

R Stupp, ME Hegi, MJ Van Den Bent, WP Mason… - The …, 2006 - academic.oup.com
Learning Objectives After completing this course, the reader will be able to: List the different
major subtypes of glioma and identify the appropriate treatment strategies for patients with …

Gliomatosis cerebri: a review of 296 cases from the ANOCEF database and the literature

S Taillibert, C Chodkiewicz, F Laigle-Donadey… - Journal of neuro …, 2006 - Springer
Gliomatosis cerebri (GC) is a rare disease, defined as a diffuse neoplastic glial cell
infiltration of the brain. Diagnosis and management of GC are difficult. This study analyzed …

Gliomatosis cerebri: clinical characteristics, management, and outcomes

S Chen, S Tanaka, C Giannini, J Morris, ES Yan… - Journal of neuro …, 2013 - Springer
Gliomatosis cerebri is a rare diffusely infiltrating primary neoplastic glial process of the brain.
Our objective is to review clinical presentation, management, and outcome in a large single …

Gliomatosis cerebri: current understanding and controversies

S Ranjan, KE Warren - Frontiers in Oncology, 2017 - frontiersin.org
Gliomatosis cerebri (GC) is a rare, extensively infiltrating glioma involving multiple
contiguous lobes of the brain. This lethal disease affects all age groups, and the majority of …

NOA‐05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri

M Glas, O Bähr, J Felsberg, K Rasch… - Annals of …, 2011 - Wiley Online Library
Objective: The NOA‐05 multicenter trial was performed to analyze the efficacy of primary
chemotherapy with procarbazine and lomustine (PC) in patients with gliomatosis cerebri …

Current and investigational drug strategies for glioblastoma

M Ajaz, S Jefferies, L Brazil, C Watts, A Chalmers - Clinical Oncology, 2014 - Elsevier
Medical treatments for glioblastoma face several challenges. Lipophilic alkylators remain the
mainstay of treatment, emphasising the primacy of good blood–brain barrier penetration …

Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebri

G Kaloshi, S Everhard, F Laigle-Donadey, Y Marie… - Neurology, 2008 - AAN Enterprises
Background: Up-front temozolomide (TMZ) has been recently proposed as a treatment for
gliomatosis cerebri (GC), but no predictive or prognostic markers have been identified so far …

Prognostic stratification of gliomatosis cerebri by IDH1R132H and INA expression

V Desestret, P Ciccarino, F Ducray, E Crinière… - Journal of neuro …, 2011 - Springer
Gliomatosis cerebri (GC) constitutes a heterogenous group of conditions involving diffuse
neoplastic glial cell infiltration of the brain. Management is difficult and an obvious challenge …

Gliomatosis cerebri: a consensus summary report from the First International Gliomatosis cerebri Group Meeting, March 26–27, 2015, Paris, France

JP Greenfield, A Castaneda Heredia… - Pediatric Blood & …, 2016 - Wiley Online Library
Gliomatosis cerebri (GC) is a universally fatal extensive and diffuse infiltration of brain
parenchyma by a glial tumor. Many aspects of this phenomenon remain unknown. The First …

Gliomatosis cerebri: a review

R Rudà, L Bertero, M Sanson - Current treatment options in neurology, 2014 - Springer
Opinion statement Gliomatosis cerebri (GC) is an intriguing disease for several reasons.
First, it is difficult to draw the border between GC and diffuse gliomas. In this regard, GC …